Friday 9th February 2018

Venue: Royal College of Physicians, 11, St. Andrews Place, London, NW1 4LE


This symposium is bringing together experts and leaders to examine in a balanced and evidence based way the relative merits of the latest surgical and transcatheter treatments of aortic valve disease. The symposium aims to inform physicians and patient advocacy groups about all the evidence (or lack of it) on choice of procedure and prosthesis. We hope that you find the programme thought provoking and rewarding.

Norman Briffa, FRCS, (CTh) Marjan Jahangiri, FRCS, (CTh)
Consultant Cardiothoracic Surgeon
Sheffield Teaching Hospital
Professor of Cardiac Surgery
St. George’s Hospital

07.45 – 08:15 Registration

08.15 – 08.30 Welcome Norman Briffa /Marjan Jahangiri
Session I: Review of trials and registries Chairs: Peter Ludman, Catherine Otto, Miguel Sousa-Uva
08.30 – 08.50 Review of European TAVI registries Pieter Kappetein
08.50 – 09.10 Review of UK TAVI Registry Peter Ludman
09.10 – 09:30 TAVI for low risk: Is it too early? Miguel Sousa-Uva
09:30 – 09.50 High risk trials Neil Moat
09.50 – 10: 10 The future – Game over or game just beginning? Michael Mack
10:10 – 10:30 Discussion

10:30 – 11:00 Coffee and Exhibitions

Session II: Less invasive SAVR – Comparison with TAVI Chairs: Peter de Jaegere, Mattia Glauber
11:00 – 11:20 Setting up a minimally invasive SAVR service –The challenges and the benefits Mattia Glauber
11:20 – 11:40 Lesser invasive approaches to SAVR Enoch Akowuah
11:40 – 12:00 Rapid deployment prostheses in SAVR Michael Borger/Renzo Pessotto
12:00 – 12:20 Update and progress in patient-specific computer simulation in cardiovascular interventions Peter de Jaegere
12.20 – 12.40 Assessment and QOL in mini SAVR vs. TAVI Marjan Jahangiri

12.40 – 13.40 Lunch and Exhibitions

Session III: Prognosis following aortic valve intervention Chairs: Nick Fletcher, Olaf Wendler
13.40 – 14.00 Mechanical vs tissue vs TAVI. Concept of PPM Catherine Otto
14:00 – 14:20 Long term results after SAVR with mechanical prostheses Michael Borger
14:20 – 14.40 Prognosis after SAVR in the elderly Catherine Otto
14.40 – 15:00 Tissue prostheses in young patients undergoing SAVR – a word of caution Norman Briffa
15.00 – 15:20 Developments in longer lasting tissue AVR and Valve-in-Valve Olaf Wendler

15:20 – 15.50 Afternoon Tea and Exhibitions

Session IV: Conclusions Chairs: Graham Cooper, Jose-Luis Pomar, Prakash Punjabi
15.50 – 16:10 Use of cardiovascular trials to distort best clinical practice David Taggart
16:10 – 16:30 Lessons learnt from PCI/CABG Julian Gunn
16:30 – 16.50 Decision record and consenting patients Bertie Leigh
16.50 – 17:10 Concluding thoughts Marjan Jahangiri


Enoch Akowuah South Tees NHS Foundation Trust
Michael Borger Heart Centre Leipzig, Leipzig
Norman Briffa Sheffield Teaching Hospital, Sheffield
Graham Cooper President, SCTS; Sheffield Teaching Hospital, Sheffield
Nick Fletcher President, ACTACC; St. George’s Hospital, London
Mattia Glauber Instituto Clinico Sant Ambrogio, Milan
Julian Gunn University of Sheffield, Sheffield
Peter de Jaegere Thorax Centre, Rotterdam
Marjan Jahangiri St. George’s Hospital, London
Pieter Kappetein Thorax Centre, Rotterdam
Bertie Leigh EACTS Lawyer, Hempsons, London
Peter Ludman Queen Elizabeth Hospital, Birmingham
Michael Mack Baylor Healthcare, Texas
Neil Moat Royal Brompton and Harefield Trust, London
Catherine Otto University of Washington School of Medicine, Seattle
Renzo Pessotto Royal Infirmary of Edinburgh
Jose-Luis Pomar Hospital Clinic & University of Barcelona, Spain
Prakash Punjabi Hammersmith Hospital, Imperial College, London
Miguel Sousa-Uva President, EACTS; Hospital Cruz Vermelha, Lisbon
David Taggart Oxford University Hospitals, Oxford
Olaf Wendler King’s College Hospital, London